CN105056367A - Instrument for treating difficult falling asleep - Google Patents
Instrument for treating difficult falling asleep Download PDFInfo
- Publication number
- CN105056367A CN105056367A CN201510503223.4A CN201510503223A CN105056367A CN 105056367 A CN105056367 A CN 105056367A CN 201510503223 A CN201510503223 A CN 201510503223A CN 105056367 A CN105056367 A CN 105056367A
- Authority
- CN
- China
- Prior art keywords
- low frequency
- ultra
- control circuit
- stimulation instrument
- transcranial magnetic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Magnetic Treatment Devices (AREA)
Abstract
The invention discloses an instrument for treating difficult falling asleep. The instrument is an ultralow-frequency transcranial magnetic stimulator and comprises a control circuit and a stimulation coil, and the control circuit controls the stimulation coil to send out magnetic fields of 1 mHz, 5 mHz and 13 mHz. The ultralow-frequency transcranial magnetic stimulator acts on the brain through the magnetic fields of 1 mHz, 5 mHz and 13 mHz, and the situation of difficulty falling asleep of a patient can be remarkably relieved. The effective rate of treating difficult falling asleep can be above 90%, and is far higher than the curative effect (effective rate of 60% to 70%) of drugs, and no side effect is observed.
Description
Technical field
The present invention relates to a kind of medical apparatus and instruments, particularly a kind of instrument for the treatment of difficulty falling asleep.
Background technology
Insomnia is an a kind of global difficult problem, is mainly Drug therapy at present, but to there is many drawbacks as undesirable in curative effect for Drug therapy, even destroys normal Sleep architecture; There is side effect as hangover phenomenon, additive and drug dependence, even can cause decrease of cognitive function etc.Therefore, provide safer and more effective Insomnia therapy mode significant.
Ultra-low frequency transcranial magnetic stimulation instrument is a kind of safe physical therapy apparatus, there are some researches show that it has certain treatment and improvement result to insomnia, cerebral palsy.Sun Yuanfeng, Li Zhe, Li Yun, Deng. the curative effect [J] of ultra-low frequency transcranial magnetic stimulation treatment of insomnia patients patient. Chinese journals of practical medicine, 2013,29 (13): 2168-2169. point out, adopt the intrasonic TMS instrument that Shenzhen Kang Li company produces, application 1 and 4mHz two kinds of frequencies, stimulus intensity is 500 Gausses, every day 1 time, each 30min, treat 2 weeks, patient is after intrasonic TMS treatment, and the curative effect according to Sleep Dysfunction Rating Scale in Patients with Insomnia deduction rate evaluation patient is: marked improvement 5 example, effective 13 examples, progressive 15 examples, invalid 2 examples.Therapeutic scheme disclosed in this file, does not carry out difference treatment to dissimilar insomnia, causes it when practical application, can not obtain gratifying effect.
The research that inventor is long-term, thinks that the insomnia of different types exists certain general character to a certain extent, but distinguishes to some extent again, design the ultra-low frequency transcranial magnetic stimulation instrument for dissimilar insomnia, can obtain better curative effect.
Summary of the invention
The object of the present invention is to provide a kind of ultra-low frequency transcranial magnetic stimulation instrument for the treatment of difficulty falling asleep.
The technical solution used in the present invention is:
Treat a ultra-low frequency transcranial magnetic stimulation instrument for difficulty falling asleep, comprise control circuit and stimulating coil, control circuit controls the magnetic field that stimulating coil periodically sends 1mHz, 5mHz and 13mHz
As the further improvement of above-mentioned ultra-low frequency transcranial magnetic stimulation instrument, control circuit controls the magnetic field that stimulating coil periodically sends 1mHz, 4mHz, 5mHz and 13mHz.
As the further improvement of above-mentioned ultra-low frequency transcranial magnetic stimulation instrument, control circuit controls the magnetic field that stimulating coil periodically sends 1mHz10 ~ 20min, 5mHz10 ~ 30min and 13mHz3 ~ 8min.
As the further improvement of above-mentioned ultra-low frequency transcranial magnetic stimulation instrument, control circuit controls the magnetic field that stimulating coil periodically sends 1mHz10 ~ 20min, 4mHz10 ~ 20min, 5mHz3 ~ 8min and 13mHz3 ~ 8min.
As the further improvement of above-mentioned ultra-low frequency transcranial magnetic stimulation instrument, control circuit controls the magnetic field that stimulating coil periodically sends 1mHz10min, 5mHz15min and 13mHz5min.
As the further improvement of above-mentioned ultra-low frequency transcranial magnetic stimulation instrument, control circuit controls the magnetic field that stimulating coil periodically sends 1mHz10min, 4mHz10min, 5mHz5min and 13mHz5min.
As the further improvement of above-mentioned ultra-low frequency transcranial magnetic stimulation instrument, the intensity in the magnetic field that ultra-low frequency transcranial magnetic stimulation instrument sends is 300 ~ 1000 Gausses.
As the further improvement of above-mentioned ultra-low frequency transcranial magnetic stimulation instrument, the intensity in the magnetic field that ultra-low frequency transcranial magnetic stimulation instrument sends is 500 ± 20% Gausses.
The invention has the beneficial effects as follows:
Ultra-low frequency transcranial magnetic stimulation instrument of the present invention, adopt specific ULF Magnetic field to act on brain, the effective percentage being used for the treatment of difficulty falling asleep can reach more than 90%, far above the curative effect (effective percentage 60%-70%) of medicine, do not observe side effect, simultaneously without additive.
Detailed description of the invention
Below in conjunction with experiment, further illustrate technical scheme of the present invention.
object
Totally 200 routine patients include research in, are divided into treatment group and false stimulating group at random.Treatment group 100 example, man 68 example, female 32 example, 43.3 ± 8.5 years old age, disease time 6 months ~ 5 years, average 18.6 ± 6.3 months; False stimulating group 100 example, man 59 example, female 41 example, 42.8 ± 8.2 years old age, disease time 6 months ~ 5 years, average 18.9 ± 7.6 months.Two groups of physical data through statistical procedures, the equal not statistically significant of difference (
p>0.05), there is comparability.
All patients are from the outpatient service insomniac in year June in July, 2013 to 2014.Enter group standard: the diagnostic criteria meeting the primary insomnia of " Americanism medical diagnosis on disease and statistic handbook " the 4th edition: main suit has difficulty in going to sleep or maintains dyskoimesis; Sleeping problems (or adjoint tired in the daytime) cause the worries or the infringement of the critical function such as social activity, occupation with clinical meaning; Get rid of the insomnia that other types sleep disordered, depression, generalized anxiety disorder, various corporality diseases etc. cause.
MethodsThe cases enrolled need meet following condition: (1) insomnia occurs weekly more than 3 evenings; (2) medical history continues to be longer than 1 month; (3) age 20-75 year; (3) active substance that is a cup too low is abused, and does not take the influential medicine of central nervous system in entering to organize first 1 week.
Treatment group patient is divided into again difficulty falling asleep group and difficulty falling asleep to merge anxiety group according to symptom, and difficulty falling asleep group: time for falling asleep is greater than 30 minutes is unique insomnia with difficulty falling asleep; Difficulty falling asleep merges anxiety group: time for falling asleep is greater than 30 minutes, merges anxiety symptom simultaneously, and Analysisof Self-rating Anxiety Scale scoring (SAS) is more than or equal to 50 points.
Exclusion standard: (1) epileptic seizures, brain organic history of disease, severe physical disease, mental retardation; (2) wine, drug dependence and psychoactive substance abuse person is had; (3) et al. Ke metal person; (4) person that is provided with cardiac pacemaker; (4) gestation or women breast-feeding their children.
therapeutic Method:
Adopt Guangzhou can husband company produce intrasonic TMS instrument, the patient of different insomnia adopts different Therapeutic mode:
The treatment of the patient of the difficulty falling asleep group scheme of pattern 1: 1mHz10 minute, 5mHz15 minute and 13mHz5 minute; Stimulate once before sleeping every day.
Difficulty falling asleep merges the scheme for the treatment of with insomnia mode 3 of the patient of anxiety: 1mHz10 minute, 4mHz10 minute, 5mHz5 minute and 13mHz5 minute; Stimulate once before sleeping every day.
During false stimulating group patient treatment, do not open " beginning " key, instrument coil no power, remaining is the same with treatment group.
observation index and therapeutic evaluation:
Scale assessment is undertaken by 2 clinical attending doctors through scale training (concordance is 84%).
Analysisof Self-rating Anxiety Scale: enter to organize patient and carry out Analysisof Self-rating Anxiety Scale assessment all before the treatment, scoring is more than or equal to 50 and is divided into merging anxiety.
Adopt Sleep Dysfunction Rating Scale in Patients with Insomnia (SleepDysfunctionRatingScale, SDRS) respectively at treating front and treating the situation that the 1st evaluates the sleep disorder of patient weekend.With Sleep Dysfunction Rating Scale in Patients with Insomnia deduction rate evaluation curative effect, deduction rate >=75% is recovery from illness, >=50% and <75% be significantly effective, >=25% and <50% for take a turn for the better, < 25% is invalid, deduction rate=(after baseline total score-treatment total score)/baseline total score.Recovery from illness and obvious effective rate sum are total effective rate.
statistical method
Adopt SPSS15.0 statistical package to carry out statistical disposition to data, compare before and after the measurement data of normal distribution and use paired t-test.Significance level gets α=0.05(bilateral), P < 0.05 has statistical significance for difference.
result
After patient treatment, clinical symptoms is improved obviously, compare before and after treatment group Sleeping Disorder in Patient rating scale assessment treatment and have obvious significant difference (P < 0.01), Sleep Dysfunction Rating Scale in Patients with Insomnia assessment no difference of science of statistics (P > 0.05) (see table 1) before and after false stimulating group patient treatment.Patient is after intrasonic TMS treatment, and according to the evaluation of Sleep Dysfunction Rating Scale in Patients with Insomnia deduction rate, difficulty falling asleep group is fully recovered 15 examples (35.71%), effective 24 examples (57.14%), 2 examples that take a turn for the better (4.76%), invalid 1 example (2.38%), total effective rate (recovery from illness+effective) is 92.85%; Difficulty falling asleep merges anxiety group and to fully recover 18 examples (31.03%), effective 35 examples (60.34%), 3 examples that take a turn for the better (5.17%), invalid 2 examples (3.44%), and total effective rate (recovery from illness+effective) is 91.37%; False stimulating group is fully recovered 2 examples (2.00%), effective 28 examples (28.00%), 30 examples that take a turn for the better (30.00%), invalid 40 examples (40.00%), and total effective rate (recovery from illness+effective) is for 30.00%(is in table 2).
Before and after table 1 treatment group and false stimulating group patient treatment, x ± s is compared in Sleep Dysfunction Rating Scale in Patients with Insomnia scoring
Table 2 treatment group is respectively divided into groups by the curative effect of SDRS total score deduction rate classification
side effect:
In therapeutic process, find no side effect.
Visible, ultra-low frequency transcranial magnetic stimulation instrument of the present invention, effectively can treat difficulty falling asleep, is one therapeutic instrument safely and effectively.
Claims (8)
1. treat a ultra-low frequency transcranial magnetic stimulation instrument for difficulty falling asleep, comprise control circuit and stimulating coil, it is characterized in that: control circuit controls the magnetic field that stimulating coil periodically sends 1mHz, 5mHz and 13mHz.
2. ultra-low frequency transcranial magnetic stimulation instrument according to claim 1, is characterized in that: control circuit controls the magnetic field that stimulating coil periodically sends 1mHz, 4mHz, 5mHz and 13mHz.
3. ultra-low frequency transcranial magnetic stimulation instrument according to claim 1, is characterized in that: control circuit controls the magnetic field that stimulating coil periodically sends 1mHz10 ~ 20min, 5mHz10 ~ 30min and 13mHz3 ~ 8min.
4. ultra-low frequency transcranial magnetic stimulation instrument according to claim 2, is characterized in that: control circuit controls the magnetic field that stimulating coil periodically sends 1mHz10 ~ 20min, 4mHz10 ~ 20min, 5mHz3 ~ 8min and 13mHz3 ~ 8min.
5. ultra-low frequency transcranial magnetic stimulation instrument according to claim 1, is characterized in that: control circuit controls the magnetic field that stimulating coil periodically sends 1mHz10min, 5mHz15min and 13mHz5min.
6. ultra-low frequency transcranial magnetic stimulation instrument according to claim 2, is characterized in that: control circuit controls the magnetic field that stimulating coil periodically sends 1mHz10min, 4mHz10min, 5mHz5min and 13mHz5min.
7. the ultra-low frequency transcranial magnetic stimulation instrument according to claim 1 ~ 6 any one, is characterized in that: the intensity in the magnetic field that ultra-low frequency transcranial magnetic stimulation instrument sends is 300 ~ 1000 Gausses.
8. ultra-low frequency transcranial magnetic stimulation instrument according to claim 7, is characterized in that: the intensity in the magnetic field that ultra-low frequency transcranial magnetic stimulation instrument sends is 500 ± 20% Gausses.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510503223.4A CN105056367A (en) | 2015-08-17 | 2015-08-17 | Instrument for treating difficult falling asleep |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510503223.4A CN105056367A (en) | 2015-08-17 | 2015-08-17 | Instrument for treating difficult falling asleep |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105056367A true CN105056367A (en) | 2015-11-18 |
Family
ID=54486016
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510503223.4A Pending CN105056367A (en) | 2015-08-17 | 2015-08-17 | Instrument for treating difficult falling asleep |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105056367A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106620989A (en) * | 2014-11-03 | 2017-05-10 | 纽沃凯生物科技（深圳）有限公司 | Method and instrument for modulating brain sleep excitation region using electromagnetic field |
| CN109125883A (en) * | 2018-10-29 | 2019-01-04 | 安生健康科技（天津）有限公司 | A kind of wearable sleeping equipment based on transcranial magnetic stimulation |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1393270A (en) * | 2001-07-04 | 2003-01-29 | 梅建德 | Controlled pulsive DC electric field equipment for inducing and exciting human electroencephalogic waves in waking state of sleeping |
| CN101491715A (en) * | 2009-02-19 | 2009-07-29 | 梅州康立高科技有限公司 | Ultra low frequency magnetic stimulation device and working method thereof |
| CN101596341A (en) * | 2009-07-10 | 2009-12-09 | 梅州康立高科技有限公司 | A kind of ultra-low frequency transcranial magnetic stimulation device and preparation method thereof |
-
2015
- 2015-08-17 CN CN201510503223.4A patent/CN105056367A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1393270A (en) * | 2001-07-04 | 2003-01-29 | 梅建德 | Controlled pulsive DC electric field equipment for inducing and exciting human electroencephalogic waves in waking state of sleeping |
| CN101491715A (en) * | 2009-02-19 | 2009-07-29 | 梅州康立高科技有限公司 | Ultra low frequency magnetic stimulation device and working method thereof |
| CN101596341A (en) * | 2009-07-10 | 2009-12-09 | 梅州康立高科技有限公司 | A kind of ultra-low frequency transcranial magnetic stimulation device and preparation method thereof |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106620989A (en) * | 2014-11-03 | 2017-05-10 | 纽沃凯生物科技（深圳）有限公司 | Method and instrument for modulating brain sleep excitation region using electromagnetic field |
| CN109125883A (en) * | 2018-10-29 | 2019-01-04 | 安生健康科技（天津）有限公司 | A kind of wearable sleeping equipment based on transcranial magnetic stimulation |
| CN109125883B (en) * | 2018-10-29 | 2024-04-02 | 安生健康科技（天津）有限公司 | Wearable sleep-aiding equipment based on transcranial magnetic stimulation |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Lei et al. | Right median nerve electrical stimulation for acute traumatic coma patients | |
| Raissi et al. | Evaluation of acupuncture in the treatment of restless legs syndrome: a randomized controlled trial | |
| Ye et al. | Effect of direct current pulse stimulating acupoints of JiaJi (T10-L3) and Ciliao (BL 32) with Han's Acupoint Nerve Stimulator on labour pain in women: a randomized controlled clinical study | |
| Liu et al. | Efficacy and Safety of Scalp Acupuncture for Insomnia: A Systematic Review and Meta‐Analysis | |
| Chen et al. | The effect of coupled inhibitory-facilitatory repetitive transcranial magnetic stimulation on shaping early reorganization of the motor network after stroke | |
| Szymoniuk et al. | Brain stimulation for chronic pain management: a narrative review of analgesic mechanisms and clinical evidence | |
| Zhang et al. | Acupuncture treatment modulate regional homogeneity of dorsal lateral prefrontal cortex in patients with amnesic mild cognitive impairment | |
| CN105056367A (en) | Instrument for treating difficult falling asleep | |
| Liu et al. | Non-invasive brain stimulation for patient with autism: a systematic review and meta-analysis | |
| Wu et al. | Update Research Advances in the Application of Transcranial Magnetic Stimulation in the Treatment of Schizophrenia | |
| CN105194803A (en) | Device used for treating poor sleeping quality | |
| Liu et al. | [Retracted] Effect of Low Frequency Repetitive Transcranial Magnetic Stimulation (rTMS) Combined with Hyperbaric Oxygen (HBO) on Awakening of Coma Patients with Traumatic Brain Injury | |
| Liu et al. | Clinical efficacy of hyperbaric oxygen combined with different timings of right median‐nerve electrical stimulation in patients with brain injury‐induced disorders of consciousness | |
| XIONG et al. | Clinical efficacy of acupoint injection for chemotherapy-induced peripheral neuropathy of patients with breast cancer | |
| Luo et al. | A systematic review and meta-analysis of acupuncture combined with Tuina in the treatment of insomnia | |
| Bi et al. | Therapeutic observation on electroacupuncture at Zusanli (ST 36) and Fenglong (ST 40) for senile dementia | |
| Zhang et al. | The effects of acupuncture on clinical efficacy and steady-state visual evoked potentials in insomnia patients with emotional disorders: A randomized single-blind sham-controlled trial | |
| Ren et al. | Acupuncture for insomnia attention deficit and the influence of nerve electrophysiology | |
| Masel | Hyperbaric oxygen therapy for traumatic brain injury: still an enigma | |
| Liu et al. | Overview of researches on central action mechanism of needling Zusanli (ST 36) | |
| Hou et al. | Study on the clinical efficacy of painting therapy of patients with anxiety disorders | |
| Yao et al. | Conducting qi and regulating the spirit needling method for insomnia: A randomized controlled trial | |
| Lan et al. | Acupuncture treatment of a pregnant patient with Bell's palsy in the third trimester: Case report | |
| Stultz et al. | 0508 Transcranial Magnetic Stimulation Shows Favorable Response for Insomnia in Depression with Greater Response in Males and in Those Less Than 65 Years of Age | |
| Yixin et al. | Results of cranial electrotherapy stimulation to children with mixed anxiety and depressive disorder |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20151118 |